$3.75
At close: Apr 15 EDT
$3.75
0.000.00%
Pre-Market: 4:01 PM EDT
Comments
Loading...
Bioage Labs Analyst Ratings and Price Targets | NASDAQ:BIOA | Benzinga
Bioage Labs Inc has a consensus price target of $5.67 based on the ratings of 4 analysts. The high is $7 issued by Jefferies on December 9, 2024. The low is $5 issued by Citigroup on March 24, 2025. The 3 most-recent analyst ratings were released by Citigroup, Morgan Stanley, and Citigroup on March 24, 2025, March 7, 2025, and December 9, 2024, respectively. With an average price target of $5.67 between Citigroup, Morgan Stanley, and Citigroup, there's an implied 51.11% upside for Bioage Labs Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Morgan Stanley
Jefferies
1calculated from analyst ratings
Analyst Ratings for Bioage Labs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/24/2025 | Buy Now | 33.33% | Citigroup | Samantha Semenkow33% | $7 → $5 | Maintains | Neutral | Get Alert |
| 03/07/2025 | Buy Now | 33.33% | Morgan Stanley | Jeffrey Hung50% | → $5 | Assumes | → Underweight | Get Alert |
| 02/28/2025 | Buy Now | — | William Blair | Andy Hsieh19% | — | Initiates | → Market Perform | Get Alert |
| 12/09/2024 | Buy Now | 86.67% | Citigroup | Samantha Semenkow33% | $45 → $7 | Downgrade | Buy → Neutral | Get Alert |
| 12/09/2024 | Buy Now | 86.67% | Jefferies | Roger Song30% | $42 → $7 | Downgrade | Buy → Hold | Get Alert |
| 10/21/2024 | Buy Now | 1100% | Citigroup | Samantha Semenkow33% | → $45 | Initiates | → Buy | Get Alert |
| 10/21/2024 | Buy Now | 966.67% | Morgan Stanley | Jeffrey Hung50% | → $40 | Initiates | → Overweight | Get Alert |
| 10/21/2024 | Buy Now | 1020% | Jefferies | Roger Song30% | → $42 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Bioage Labs (BIOA) stock?
The latest price target for Bioage Labs (NASDAQ:BIOA) was reported by Citigroup on March 24, 2025. The analyst firm set a price target for $5.00 expecting BIOA to rise to within 12 months (a possible 33.33% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bioage Labs (BIOA)?
The latest analyst rating for Bioage Labs (NASDAQ:BIOA) was provided by Citigroup, and Bioage Labs maintained their neutral rating.
When was the last upgrade for Bioage Labs (BIOA)?
There is no last upgrade for Bioage Labs
When was the last downgrade for Bioage Labs (BIOA)?
The last downgrade for Bioage Labs Inc happened on December 9, 2024 when Citigroup changed their price target from $45 to $7 for Bioage Labs Inc.
When is the next analyst rating going to be posted or updated for Bioage Labs (BIOA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bioage Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bioage Labs was filed on March 24, 2025 so you should expect the next rating to be made available sometime around March 24, 2026.
Is the Analyst Rating Bioage Labs (BIOA) correct?
While ratings are subjective and will change, the latest Bioage Labs (BIOA) rating was a maintained with a price target of $7.00 to $5.00. The current price Bioage Labs (BIOA) is trading at is $3.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.